
Friedrich Fahnert
Examiner (ID: 7481, Phone: (571)270-7797 , Office: P/2654 )
| Most Active Art Unit | 2654 |
| Art Unit(s) | 2614, 2692, 2654, 2651 |
| Total Applications | 770 |
| Issued Applications | 644 |
| Pending Applications | 40 |
| Abandoned Applications | 106 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10947199
[patent_doc_number] => 20140350220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-27
[patent_title] => 'NOVEL SURFACE EXPOSED HAEMOPHILUS INFLUENZAE PROTEIN (PROTEIN; pE)'
[patent_app_type] => utility
[patent_app_number] => 14/109573
[patent_app_country] => US
[patent_app_date] => 2013-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 25455
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14109573
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/109573 | Surface exposed Haemophilus influenzae protein (protein; pE) | Dec 16, 2013 | Issued |
Array
(
[id] => 9561838
[patent_doc_number] => 20140179550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'IMMUNOGLOBULIN FC LIBRARIES'
[patent_app_type] => utility
[patent_app_number] => 14/105642
[patent_app_country] => US
[patent_app_date] => 2013-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 54
[patent_no_of_words] => 27708
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14105642
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/105642 | Immunoglobulin Fc libraries | Dec 12, 2013 | Issued |
Array
(
[id] => 9568672
[patent_doc_number] => 20140186385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'POTOMAC HORSE FEVER ISOLATES'
[patent_app_type] => utility
[patent_app_number] => 14/101659
[patent_app_country] => US
[patent_app_date] => 2013-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 11776
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14101659
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/101659 | Potomac horse fever isolates | Dec 9, 2013 | Issued |
Array
(
[id] => 9383474
[patent_doc_number] => 20140086955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'Attenuated Live Vaccines for Aquatic Animals'
[patent_app_type] => utility
[patent_app_number] => 14/093120
[patent_app_country] => US
[patent_app_date] => 2013-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 22282
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14093120
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/093120 | Attenuated Live Vaccines for Aquatic Animals | Nov 28, 2013 | Abandoned |
Array
(
[id] => 9916751
[patent_doc_number] => 20150071956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-12
[patent_title] => 'NOVEL SURFACE EXPOSED HAEMOPHILUS INFLUENZAE PROTEIN (PROTEIN E; pE)'
[patent_app_type] => utility
[patent_app_number] => 14/085007
[patent_app_country] => US
[patent_app_date] => 2013-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 25687
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14085007
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/085007 | NOVEL SURFACE EXPOSED HAEMOPHILUS INFLUENZAE PROTEIN (PROTEIN E; pE) | Nov 19, 2013 | Abandoned |
Array
(
[id] => 10614878
[patent_doc_number] => 09334311
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-10
[patent_title] => 'Chimeric OspA genes, proteins and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 14/078367
[patent_app_country] => US
[patent_app_date] => 2013-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 45260
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 383
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14078367
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/078367 | Chimeric OspA genes, proteins and methods of use thereof | Nov 11, 2013 | Issued |
Array
(
[id] => 9490624
[patent_doc_number] => 20140141030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'CHIMERIC OSPA GENES, PROTEINS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/078390
[patent_app_country] => US
[patent_app_date] => 2013-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 43778
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14078390
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/078390 | Chimeric OspA proteins and methods of use thereof | Nov 11, 2013 | Issued |
Array
(
[id] => 10399769
[patent_doc_number] => 20150284779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => 'DETERMINATION OF A TENDENCY TO GAIN WEIGHT'
[patent_app_type] => utility
[patent_app_number] => 14/436219
[patent_app_country] => US
[patent_app_date] => 2013-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18102
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14436219
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/436219 | DETERMINATION OF A TENDENCY TO GAIN WEIGHT | Oct 16, 2013 | Abandoned |
Array
(
[id] => 10382244
[patent_doc_number] => 20150267249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'DETERMINATION OF REDUCED GUT BACTERIAL DIVERSITY'
[patent_app_type] => utility
[patent_app_number] => 14/436149
[patent_app_country] => US
[patent_app_date] => 2013-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 34843
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14436149
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/436149 | DETERMINATION OF REDUCED GUT BACTERIAL DIVERSITY | Oct 16, 2013 | Abandoned |
Array
(
[id] => 10390267
[patent_doc_number] => 20150275275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'PROGNOSTIC OF DIET IMPACT ON OBESITY-RELATED CO-MORBIDITIES'
[patent_app_type] => utility
[patent_app_number] => 14/435736
[patent_app_country] => US
[patent_app_date] => 2013-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14469
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435736
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/435736 | PROGNOSTIC OF DIET IMPACT ON OBESITY-RELATED CO-MORBIDITIES | Oct 16, 2013 | Abandoned |
Array
(
[id] => 9478017
[patent_doc_number] => 20140135481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'HUMANIZED MONOCLONAL ANTIBODIES THAT PROTECT AGAINST SHIGA TOXIN INDUCED DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/036835
[patent_app_country] => US
[patent_app_date] => 2013-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 9008
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14036835
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/036835 | HUMANIZED MONOCLONAL ANTIBODIES THAT PROTECT AGAINST SHIGA TOXIN INDUCED DISEASE | Sep 24, 2013 | Abandoned |
Array
(
[id] => 11805194
[patent_doc_number] => 09546207
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-17
[patent_title] => 'Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/028117
[patent_app_country] => US
[patent_app_date] => 2013-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 108
[patent_no_of_words] => 49086
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14028117
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/028117 | Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereof | Sep 15, 2013 | Issued |
| 13/988339 | MALARIA VACCINES BASED ON PRE-ERYTHROCYTIC ANTIGENS FROM P. FALCIPARUM | Aug 6, 2013 | Abandoned |
Array
(
[id] => 9881981
[patent_doc_number] => 08968739
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-03
[patent_title] => 'Antibody and methods for selective inhibition of T-cell responses'
[patent_app_type] => utility
[patent_app_number] => 13/946450
[patent_app_country] => US
[patent_app_date] => 2013-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 42
[patent_no_of_words] => 47514
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13946450
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/946450 | Antibody and methods for selective inhibition of T-cell responses | Jul 18, 2013 | Issued |
Array
(
[id] => 14521633
[patent_doc_number] => 10338067
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-07-02
[patent_title] => Rapid analysis for cyanobacterial toxins
[patent_app_type] => utility
[patent_app_number] => 13/941524
[patent_app_country] => US
[patent_app_date] => 2013-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 11921
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13941524
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/941524 | Rapid analysis for cyanobacterial toxins | Jul 13, 2013 | Issued |
| 13/906386 | CAMELIDAE SINGLE-DOMAIN ANTIBODIES AGAINST YERSINIA PESTIS | May 30, 2013 | Abandoned |
Array
(
[id] => 12466302
[patent_doc_number] => 09987342
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-05
[patent_title] => Immunizing composition
[patent_app_type] => utility
[patent_app_number] => 13/893212
[patent_app_country] => US
[patent_app_date] => 2013-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 22
[patent_no_of_words] => 12949
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13893212
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/893212 | Immunizing composition | May 12, 2013 | Issued |
Array
(
[id] => 16604777
[patent_doc_number] => 10905761
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-02
[patent_title] => Use of a lipopeptide or lipoprotein as an adjuvant in therapeutic or prophylactic vaccinations
[patent_app_type] => utility
[patent_app_number] => 13/848936
[patent_app_country] => US
[patent_app_date] => 2013-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9035
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13848936
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/848936 | Use of a lipopeptide or lipoprotein as an adjuvant in therapeutic or prophylactic vaccinations | Mar 21, 2013 | Issued |
Array
(
[id] => 9093779
[patent_doc_number] => 20130273089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'ANTIBODY AND METHODS FOR SELECTIVE INHIBITION OF T-CELL RESPONSES'
[patent_app_type] => utility
[patent_app_number] => 13/844434
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 49922
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13844434
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/844434 | ANTIBODY AND METHODS FOR SELECTIVE INHIBITION OF T-CELL RESPONSES | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9081442
[patent_doc_number] => 20130266972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-10
[patent_title] => 'METHOD OF DETECTING PROTEIN LOSING ENTEROPATHY IN ANIMALS'
[patent_app_type] => utility
[patent_app_number] => 13/837023
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2026
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13837023
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/837023 | METHOD OF DETECTING PROTEIN LOSING ENTEROPATHY IN ANIMALS | Mar 14, 2013 | Abandoned |